Filing Flows › Invo Fertility (IVF) › Q2 2025
Invo Fertility (IVF) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Invo Fertility (IVF) reported revenue of $1.9M for the second quarter 2025 (Q2 2025), +1% from a year earlier and +14% from the quarter before. Operating margin was -160.4%, net loss $6.8M (365.7% of revenue).
Invo Fertility, Q2 2025: revenue $1.9M (+2% year over year), operating margin -160.4%, net loss $6.8M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | +14% | +1% |
| Operating profit | −$3.0M | — | — |
| Net earnings | −$6.8M | — | — |
| Operating cash flow | −$1.7M | — | — |
What changed
Revenue was $1.9M in Q2 2025, up 1% year over year and up 14% from the previous quarter. Clinic Revenue was the largest line at 98% of revenue. Clinic Revenue added $24K year over year (up 1%), 89% of the total change.
Operating costs exceeded revenue by $3.0M, an operating margin of -160.4%. Total costs grew 32% against revenue growth of 1%. The fastest-growing cost line was Other operating costs (+1374%). The quarter ended with a net loss of $6.8M, narrower than the previous quarter's $17.4M loss. Minority interests bore $1.5M of it: to shareholders the quarter was a loss of $5.3M.
Operating cash flow was −$1.7M. Non-cash charges added back $170K of depreciation and amortization. Working capital and other items added $4.9M. Capital expenditures of $9K exceeded it, leaving free cash flow of −$1.7M.
Questions
What was Invo Fertility's revenue in the second quarter 2025?
Invo Fertility (IVF) reported revenue of $1.9M for the second quarter 2025 (Q2 2025), +1% from a year earlier and +14% from the quarter before.
Was Invo Fertility profitable in the second quarter 2025?
Operating loss was $3.0M (-160.4% of revenue) and net loss $6.8M.
Source: Invo Fertility 10-Q on SEC EDGAR.